S050 Late-Breaking Research: Session 2
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
Investigators can submit abstracts describing their most recent unpublished results in all aspects of dermatological research. After a competitive review, the top-scoring studies will be invited to discuss their findings in a brief oral presentation. Emphasis will be placed on practice-changing clinical trials, large population-based studies, innovative new transformative technologies, translationally relevant biomarker studies, and basic science research that sheds light on mechanisms of disease, therapy, or adverse events. All topics related to disorders of the skin, hair and nails will be considered.
LEARNING OBJECTIVES
Describe ground-breaking scientific developments in dermatologic research.
Evaluate and apply information from recent investigations to clinical practice.
SCHEDULE
8:00 PM
Efficacy and Safety of Oral Povorcitinib in Patients With Prurigo Nodularis: Results From a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study
Martin Metz
8:10 PM
Efficacy and Safety of Ruxolitinib Cream in Patients With Hidradenitis Suppurativa (Hurley Stage I and II): Results From a Randomized, Double-Blind, Vehicle-Controlled Phase 2 Study
Martina J Porter, MD, FAAD
8:20 PM
Efficacy and Safety of a Highly Selective Oral TYK2/JAK1 Inhibitor, ICP-332, in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase II, Randomized, Placebo-Controlled Trial
8:30 PM
Efficacy and safety of amlitelimab (an OX40 ligand antibody) in patients with moderate-to-severe atopic dermatitis: 52-week results from a Phase 2b trial (STREAM-AD)
Stephan Weidinger
8:40 PM
Inflammatory skin disease following the use of SGLT2 inhibitors for diabetes mellitus
Allison Holt
8:50 PM
Deceleration in Melanoma Mortality between 1969-2014
David Latoni, MPH
9:00 PM
Efficacy and safety of the IL-17A- and IL-17F-inhibiting Nanobody® sonelokimab in patients with moderate-to-severe hidradenitis suppurativa (HS): Week 24 results from the Phase 2 MIRA trial
Brian Kirby
9:10 PM
Deuruxolitinib Demonstrates Significant and Continual Improvement in Scalp Hair Regrowth at 68 Weeks of Dosing in Patients With Alopecia Areata: Pooled Efficacy Results From Ongoing Open-Label Extensi
Brett Andrew King, MD, PhD, FAAD
9:20 PM
Efficacy and safety of lebrikizumab in adult and adolescent patients with skin of color and moderate-to-severe atopic dermatitis: An interim analysis of the open-label Phase 3b trial, ADmirable
Jill S. Waibel, MD, FAAD
9:30 PM
Efficacy and Safety of Once-Daily Roflumilast Cream 0.05% in Pediatric Patients 2 to 5 Years of Age with Mild to Moderate Atopic Dermatitis (INTEGUMENT-PED): A Phase 3 Randomized Controlled Trial
Lawrence F Eichenfield, MD, FAAD
9:40 PM
Single-cell profiling of alopecia areata highlights differences in activation of immunotherapeutic targets in patients with and without atopy
Helen Y He, MD
9:50 PM
Maintenance of efficacy and safety with nemolizumab at Week 48: Results from two global phase 3 pivotal studies (ARCADIA-1 and ARCADIA-2) in patients with moderate-to-severe atopic dermatitis
Jonathan I. Silverberg, MD, PhD, MPH, FAAD
10:00 PM
Efficacy, Safety and Pharmacokinetics of First 17 Adult and Adolescent Subjects in Maximal Use Portion of Vehicle Controlled ASCEND Trial of Polyethylene Glycol (iPEG™)-Based Topical Isotretinoin 0.0
Christopher Bunick, PhD, MD, FAAD
10:10 PM
Hair regrowth in patients with severe alopecia areata receiving long-term continuous treatment with baricitinib 4 mg up to Week 76
Rodney Daniel Sinclair, MD, IFAAD
10:20 PM
Nemolizumab long-term efficacy and safety up to 52 weeks in the OLYMPIA open- label extension study in patients with prurigo nodularis: An Interim analysis
Shawn Kwatra, MD, FAAD
10:30 PM
Efficacy and safety of topical 1% benvitimod cream for atopic dermatitis in adults and children of two years and above: A randomized, multicentre, and placebo-controlled pivotal study
Jianzhong Zhang, MD
10:40 PM
Genome-wide association study identifying genetic variants associated with atopic dermatitis in the All of Us database
Nicole Johnsen
10:50 PM
Long-Term Efficacy and Safety of SHR0302 in Patients with Moderate-to-Severe Atopic Dermatitis
Yan Zhao, MD
SPEAKERS
Andrew F. Alexis, MPH, MD, FAAD
Andrew Blauvelt, MD, FAAD
Christopher Bunick, PhD, MD, FAAD
Robert Paul Dellavalle, MD, PhD, FAAD
Lawrence F Eichenfield, MD, FAAD
Joel M. Gelfand, MD, MSCE, FAAD
Kenneth B. Gordon, MD, FAAD
Helen Y He, MD
Allison Holt
Nicole Johnsen
Sewon Kang, MD, FAAD
Brett Andrew King, MD, PhD, FAAD
Brian Kirby
Shawn Kwatra, MD, FAAD
David Latoni, MPH
Martin Metz
Paul Nghiem, MD, PhD, FAAD
Amy S. Paller, MD, FAAD
Martina J Porter, MD, FAAD
Jonathan I. Silverberg, MD, PhD, MPH, FAAD
Rodney Daniel Sinclair, MD, IFAAD
Hensin Tsao, MD, PhD, FAAD
Sandy Sharon Tsao, MD, FAAD
Jill S. Waibel, MD, FAAD
Stephan Weidinger
Jianzhong Zhang, MD
Qiang Zhang
Yan Zhao, MD
HANDOUTS
SPEAKER DISCLOSURES
Andrew F. Alexis, MPH, MD, FAAD
AbbVie – Advisory Board(Honoraria), Consultant(Fees), Investigator(Grants/Research Funding); Aerolase – Other(Equipment); Allergan, Inc. – Advisory Board(Honoraria); Almirall – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Alphyn Biologics – Advisory Board(Honoraria); Amgen – Consultant(Fees), Investigator(Grants/Research Funding); Apogee BioPharm – Advisory Board(Honoraria); Arcutis Biotherapeutics – Investigator(Grants/Research Funding); Arcutis, Inc. – Advisory Board(Honoraria); Bausch Health – Advisory Board(Honoraria); Beiersdorf, Inc. – Advisory Board(Honoraria); Bristol-Myers Squibb – Advisory Board(Fees), Speaker(Honoraria); Canfield Scientific, Inc. – Consultant (1099 relationship)(Fees); Cara Therapeutics – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Castle Biosciences – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Covington & Burling LLP – Other(Fees); Cutera, Inc. – Consultant(Fees); Dermavant Sciences – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Dermavant Sciences, Inc. – Advisory Board(Honoraria); Eli Lilly – Consultant(Fees); Eli Lilly and Company – Advisory Board(Honoraria); EPI Health – Advisory Board(Honoraria); Foundation for Research & Education of Dermatology – Advisory Board(Honoraria); Galderma Laboratories, L.P. – Advisory Board(Honoraria), Consultant(Fees), Investigator(Grants/Research Funding); Incyte – Advisory Board(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria); Janssen Scientific Affairs, LLC – Consultant(Honoraria); Johnson and Johnson – Speaker(Honoraria); L'Oréal France – Advisory Board(Honoraria), Speaker(Honoraria); L'Oreal USA Inc. – Advisory Board(Honoraria), Consultant(Fees), Speaker(Honoraria); Leo Pharma Inc – Consultant(Fees); Leo Pharma Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Medscape – Other(Honoraria); Novartis – Advisory Board(Honoraria); OptiNose Inc. – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Fees), Advisory Board(Honoraria); RBC Consultants – Advisory Board(Honoraria); Regeneron – Advisory Board(Honoraria); Sanofi Genzyme – Advisory Board(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria), Speaker/Faculty Education(Honoraria); Sanova Works – Speaker(Honoraria); Springer Science & Business Media – Other(Other Financial Benefit); Swiss American – Advisory Board(Honoraria); UCB – Advisory Board(Fees); UpToDate, Inc. – Other(Other Financial Benefit); VisualDx – Advisory Board(Honoraria); Wiley-Blackwell – Other(Other Financial Benefit);
Andrew Blauvelt, MD, FAAD
AbbVie – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Fees); Almirall – Advisory Board(Honoraria), Consultant(Honoraria); Alumis – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Fees); Amgen – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Fees); AnaptysBio – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Fees); Apogee Therapeutics – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Arcutis, Inc. – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Fees); Boehringer Ingelheim – Advisory Board(Honoraria), Consultant(Honoraria); Bristol-Myers Squibb – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding); Dermavant Sciences – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Fees); Eli Lilly and Company – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Fees), Speaker(Honoraria); Galderma Laboratories, L.P. – Advisory Board(Honoraria), Consultant(Honoraria); Galderma USA – Investigator(Fees); GlaxoSmithKline Immunology – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Incyte Corporation – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Fees); Janssen-Ortho Inc. – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Fees); Leo Pharma Inc – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Fees); Lipidio Pharmaceuticals – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Stockholder Private Company(Stock); Merck – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Novartis Pharmaceuticals Corp. – Advisory Board(Honoraria), Consultant(Honoraria); Oruka Therapeutics – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Stockholder Public Company(Stock); Pfizer Inc. – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Fees); Regeneron – Advisory Board(Honoraria), Consultant(Honoraria); Sanofi – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Fees); Sun Pharmaceutical Industries Ltd. – Advisory Board(Honoraria), Consultant(Honoraria); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Fees); UCB – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Fees), Speaker(Honoraria); Union Therapeutics – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria);
Christopher Bunick, PhD, MD, FAAD
AbbVie – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Advisory Boards - South Beach Symposium – Advisory Board(Fees); Almirall – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Apogee Therapeutics – Consultant (1099 relationship)(Fees); Arcutis Biotherapeutics – Consultant (1099 relationship)(Fees); Daiichi Sankyo – Investigator(Grants/Research Funding); Eli Lilly – Consultant (1099 relationship)(Fees); LEO Pharma, US – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); Novan – Consultant (1099 relationship)(Fees); Novartis – Advisory Board(Honoraria); Ortho Dermatologics – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Palvella Therapeutics – Investigator(Grants/Research Funding); Pfizer Inc. – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); Sanofi – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Investigator(Grants/Research Funding); Timber Pharmaceuticals – Investigator(Grants/Research Funding); UCB – Advisory Board(Honoraria);
Robert Paul Dellavalle, MD, PhD, FAAD
No financial relationships exist with ineligible companies.
Lawrence F Eichenfield, MD, FAAD
AbbVie – Consultant(Honoraria); Abbvie – Investigator(Grants/Research Funding); Almirall – Consultant(Honoraria); Amgen – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Amryt Pharma – Consultant(Honoraria); Arcutis Biotherapeutics – Investigator(Grants/Research Funding); ASLAN Pharmaceuticals – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Bristol-Myers Squibb – Consultant(Honoraria); Castle Biosciences, Inc – Investigator(Grants/Research Funding); Dermata Therapeutics – Consultant (1099 relationship)(Stock); Dermavant Sciences, Inc. – Consultant(Honoraria); Eli Lilly – Consultant(Honoraria), Investigator(Grants/Research Funding); Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights); Forte Biosciences – Board of Directors(Fees), Board of Directors(Stock Options); Galderma Laboratories, L.P. – Consultant(Honoraria), Investigator(Fees); Incyte Corporation – Consultant(Honoraria); Janssen Pharmaceuticals, Inc – Consultant (1099 relationship)(Honoraria); Krystal Biotech, Inc – Consultant(Honoraria); LEO Pharma, US – Consultant(Honoraria), Investigator(Fees); Lilly ICOS LLC – Consultant(Honoraria); Nobelpharma – Consultant(Honoraria); Ortho Dermatologics – Investigator(Grants/Research Funding); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Sanofi/Regeneron – Consultant(Honoraria), Investigator(Fees); TopMD – Consultant(Stock Options); TrialSpark, Inc. – Consultant(Honoraria); UCB – Consultant(Honoraria); Verrica Pharmaceuticals Inc – Board of Directors(Fees), Board of Directors(Stock Options); Wiley-Blackwell – Other(Honoraria);
Joel M. Gelfand, MD, MSCE, FAAD
AbbVie – Consultant(Fees); Abcentra – Consultant(Fees); Amgen – Investigator(Grants/Research Funding); Artax Biopharma – Data Safety Monitoring Board(Fees); BMS – Consultant(Fees); Boehringer Ingelheim – Consultant(Honoraria), Investigator(Grants/Research Funding); CellDex – Data Safety Monitoring Board(Fees); Daavlin Company – Other(Equipment); FIDE – Consultant(Fees); GlaxoSmithKline – Consultant(Honoraria); Happify – Consultant(Fees); Healio – Other(Fees); Imagine – Data Safety Monitoring Board(Fees); Inmagene Biopharmaceuticals – Data Safety Monitoring Board(Fees); Janssen Pharmaceuticals, Inc – Consultant(Honoraria), Investigator(Grants/Research Funding); Leo Pharma Inc – Consultant(Fees); Mindera – Consultant(Fees); Moonlake – Data Safety Monitoring Board(Fees); National Psoriasis Foundation – Investigator(Grants/Research Funding); Neumentum, Inc. – Consultant(Fees); Neuroderm LTD – Other(Fees); Novartis Pharmaceuticals Corp. – Consultant(Honoraria), Investigator(Grants/Research Funding); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); UCB – Other(Fees); Veolia North America – Consultant(Fees);
Kenneth B. Gordon, MD, FAAD
AbbVie – Consultant(Honoraria), Investigator(Grants/Research Funding); Almirall – Consultant(Honoraria); Amgen – Consultant(Honoraria); Arcutis, Inc. – Consultant(Honoraria); Boehringer Ingelheim – Consultant(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Consultant(Honoraria); Dermavant Sciences – Consultant(Honoraria); Eli Lilly and Company – Investigator(Grants/Research Funding); Incyte Corporation – Consultant(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Leo Pharma Inc – Consultant(Honoraria); Lilly ICOS LLC – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Novartis Pharmaceuticals Corp. – Advisory Board(Honoraria); Othro Dermatologics – Consultant(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Protagonist Therapeutics – Consultant (1099 relationship)(Honoraria); Sanofi Genzyme – Consultant(Honoraria); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); UCB – Consultant(Honoraria);
Helen Y He, MD
No financial relationships exist with ineligible companies.
Allison Holt
No financial relationships exist with ineligible companies.
Nicole Johnsen
No financial relationships exist with ineligible companies.
Sewon Kang, MD, FAAD
Allergan, Inc – Advisory Board(Honoraria); CeraVe/Valeante – Advisory Board(Honoraria); Galderma USA – Advisory Board(Honoraria); Walgreens Boots Alliance, Inc. – Investigator(Grants/Research Funding);
Brett Andrew King, MD, PhD, FAAD
AbbVie – Advisory Board(Honoraria), Speaker(Honoraria); AnaptysBio – Consultant(Fees), Investigator(Fees); Arena Pharmaceuticals – Consultant(Fees), Investigator(Fees); ASLAN Pharmaceuticals – Consultant (1099 relationship)(Fees), Investigator(Fees); BiologicsMD, Inc. – Consultant(Stock Options); Bristol-Myers Squibb – Advisory Board(Honoraria), Consultant(Fees), Data Safety Monitoring Board(Fees); Concert Pharmaceuticals – Consultant(Fees), Investigator(Fees); Eli Lilly and Company – Consultant(Fees), Investigator(Fees), Speaker(Honoraria); Equillium, Inc. – Consultant(Fees); Horizon Pharma, Inc. – Consultant(Fees); Incyte Corporation – Advisory Board(Honoraria), Consultant(Fees), Data Safety Monitoring Board(Fees), Speaker(Honoraria); Janssen Pharmaceuticals, Inc – Consultant(Fees); Pfizer Inc. – Advisory Board(Fees), Advisory Board(Honoraria), Consultant(Fees), Investigator(Fees), Speaker(Honoraria); Q32 Bio Inc. – Consultant (1099 relationship)(Fees), Investigator(Fees); Regeneron – Speaker(Honoraria); Sanofi Genzyme – Speaker(Honoraria); TWi Biotechnology, Inc. – Consultant(Fees);
Brian Kirby
AbbVie – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Almirall – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Honoraria); Celgene – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Eli Lilly – Advisory Board(Honoraria); GlaxoSmithKline Immunology – Advisory Board(Honoraria); MC2 Therapeutics – Consultant (1099 relationship)(Honoraria); Merck & Co., Inc – Consultant (1099 relationship)(Grants/Research Funding), Investigator(Grants/Research Funding); MoonLake Immunotherapeutics – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Honoraria); Novartis – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Pfizer Inc. – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Honoraria); UCB – Advisory Board(Honoraria), Investigator(Grants/Research Funding);
Shawn Kwatra, MD, FAAD
AbbVie – Consultant(Honoraria); Amgen – Advisory Board(Honoraria); Arcutis Biotherapeutics – Advisory Board(Honoraria); ASLAN Pharmaceuticals – Consultant(Honoraria); Cara Therapeutics – Advisory Board(Honoraria); Castle Biosciences, Inc – Consultant(Honoraria); Celldex – Consultant(Honoraria); Galderma – Investigator(Grants/Research Funding); Galderma USA – Consultant(Honoraria); Incyte Corporation – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Johnson and Johnson – Advisory Board(Honoraria); Leo Pharma Inc – Advisory Board(Honoraria); Novartis – Consultant(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Regeneron – Advisory Board(Honoraria); Sanofi – Advisory Board(Honoraria), Investigator(Grants/Research Funding);
David Latoni, MPH
No financial relationships exist with ineligible companies.
Martin Metz
Alk-Abelló – Speaker/Faculty Education(Honoraria); Almirall – Speaker(Honoraria), Speaker/Faculty Education(Honoraria); Amgen – Advisory Board(Honoraria); argenx – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); AstraZeneca – Advisory Board(Honoraria); Celldex – Advisory Board(Honoraria); Celltrion – Speaker(Honoraria); Escient Pharmaceuticals, Inc – Consultant (1099 relationship)(Honoraria); Galderma – Advisory Board(Honoraria), Speaker(Honoraria); GlaxoSmithKline Immunology – Advisory Board(Honoraria); Incyte Corporation – Advisory Board(Honoraria); Jasper Therapeutics – Advisory Board(Honoraria); Novartis – Advisory Board(Honoraria), Speaker(Honoraria); Pfizer Inc. – Speaker(Honoraria); Regeneron Pharmaceuticals, Inc. – Advisory Board(Honoraria); Sanofi – Advisory Board(Honoraria), Speaker(Honoraria); Teva Pharmaceuticals USA – Consultant (1099 relationship)(Honoraria); Vifor Pharma – Speaker(Honoraria);
Paul Nghiem, MD, PhD, FAAD
Almirall – Consultant(Honoraria); Bristol-Myers Squibb – Investigator(Grants/Research Funding); EMD Serono – Consultant(Fees); Merck & Co., Inc – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria);
Amy S. Paller, MD, FAAD
AbbVie – Consultant(Honoraria), Investigator(Grants/Research Funding); Apogee BioPharm – Consultant (1099 relationship)(Honoraria); Applied Pharma Research – Investigator(Grants/Research Funding); Arcutis Biotherapeutics – Consultant (1099 relationship)(Honoraria); ASLAN Pharmaceuticals – Consultant (1099 relationship)(Honoraria); BioCryst Pharmaceuticals, Inc. – Consultant (1099 relationship)(Honoraria); Biomendics LLC – Investigator(Grants/Research Funding); Boehringer Ingelheim – Consultant(Honoraria); Bristol-Myers Squibb – Consultant(Honoraria); Dermavant Sciences, Inc. – Investigator(Grants/Research Funding); Galderma Laboratories, L.P. – Consultant(Honoraria); Incyte Corporation – Investigator(Grants/Research Funding); Krystal Biotech, Inc – Consultant(Honoraria), Investigator(Grants/Research Funding); L'Oréal France – Consultant (1099 relationship)(Honoraria); Leo Pharma Inc – Consultant(Honoraria); Mitsubishi Tanabe Pharma Corporation – Consultant (1099 relationship)(Honoraria); MoonLake Immunotherapeutics – Consultant (1099 relationship)(Honoraria); Procter and Gamble – Consultant (1099 relationship)(Honoraria); Regeneron – Consultant(Honoraria), Investigator(Grants/Research Funding); Sanofi Genzyme – Consultant(Honoraria); Timber Pharmaceuticals – Investigator(Grants/Research Funding); UCB – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding);
Martina J Porter, MD, FAAD
AbbVie – Consultant (1099 relationship)(No Compensation Received), Investigator(Grants/Research Funding); Alumis – Consultant(Fees); AnaptysBio – Investigator(Grants/Research Funding); Bayer – Investigator(Grants/Research Funding); Beth Israel Deaconess Medical Center – Other(Patent royalties or other compensation for Intellectual Property Rights); Bristol-Myers Squibb – Investigator(Grants/Research Funding); Eli Lilly – Consultant (1099 relationship)(No Compensation Received); Eli Lilly and Company – Investigator(Grants/Research Funding); FIDE – Consultant (1099 relationship)(Fees); Incyte Corporation – Consultant(Fees), Investigator(Grants/Research Funding); Janssen Pharmaceuticals, Inc – Investigator(Grants/Research Funding); Janssen Research & Development, LLC – Consultant(Fees); Mirador – Investigator(Grants/Research Funding); Moonlake – Investigator(Grants/Research Funding); MoonLake Immunotherapeutics – Consultant (1099 relationship)(Fees); National Psoriasis Foundation – Speaker(Honoraria); Novartis – Consultant(Fees), Investigator(Grants/Research Funding); Oasis Pharmaceuticals – Investigator(Grants/Research Funding); Pfizer Inc. – Consultant(Fees), Investigator(Grants/Research Funding); Prometheus Laboratories, Inc. – Consultant (1099 relationship)(No Compensation Received), Investigator(Grants/Research Funding); Regeneron – Investigator(Grants/Research Funding); Sanofi – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Sonoma Biotherapeutics – Consultant (1099 relationship)(No Compensation Received), Investigator(Grants/Research Funding); Trifecta Clinical – Consultant(Fees); UCB – Consultant(Fees), Investigator(Grants/Research Funding); Zura Bio – Consultant (1099 relationship)(Fees);
Jonathan I. Silverberg, MD, PhD, MPH, FAAD
AbbVie – Consultant(Honoraria), Investigator(No Compensation Received), Speaker(Honoraria); Aldena Therapeutics – Consultant(Fees); Amgen – Consultant(Fees); AOBiome, LLC – Consultant(Fees); Arcutis, Inc. – Consultant(Fees); Arena Pharmaceuticals – Consultant(Fees); Asana Biosciences, LLC – Consultant(Honoraria); ASLAN Pharmaceuticals – Consultant(Fees); Attovia – Advisory Board(Fees); Attovia Therapeutics – Advisory Board(Fees); BiomX Inc. – Consultant(Fees); Biosion – Consultant(Fees); Bodewell – Consultant(Fees); Boehringer Ingelheim – Advisory Board(Fees); Cara Therapeutics – Consultant(Fees); Castle Biosciences – Consultant(Fees); Celgene – Advisory Board(Fees); Connect Biopharma LLC – Consultant(Fees); Corrona, Inc. – Advisory Board(Honoraria); Dermavant Sciences – Consultant(Fees); Eli Lilly and Company – Consultant(Honoraria), Investigator(No Compensation Received), Speaker(Fees); Galderma Research & Development, LLC – Consultant(Honoraria); GlaxoSmithKline – Consultant(Honoraria), Investigator(No Compensation Received); Incyte Corporation – Consultant(Honoraria), Speaker(Honoraria); Inmagene Biopharmaceuticals – Consultant (1099 relationship)(Fees); Kiniksa Pharmaceuticals, Ltd. – Investigator(No Compensation Received); Leo Pharma Inc – Advisory Board(Honoraria), Speaker(Honoraria); Leo Pharma Inc. – Investigator(Honoraria); Maui Derm – Speaker(Fees); Novartis – Consultant(Fees); Optum – Investigator(Fees); Pfizer Inc. – Advisory Board(Honoraria), Consultant(Honoraria), Speaker(Fees); RAPT Therapeutics – Advisory Board(Fees); Regeneron – Consultant(Honoraria), Investigator(No Compensation Received), Speaker(Honoraria); Sanofi – Consultant(Grants/Research Funding); Sanofi Genzyme – Speaker(Honoraria); Shaperon – Consultant(Fees); TARGET Pharma – Advisory Board(Honoraria), Investigator(No Compensation Received); Union Therapeutics – Consultant(Fees); UpToDate – Other(Fees);
Rodney Daniel Sinclair, MD, IFAAD
AbbVie – Advisory Board(Fees); Aclaris Therapeutics Inc. – Investigator(Fees); Amgen – Investigator(Fees); Ascend Pharmaceuticals, Inc. – Board of Directors(Fees); Bayer – Speaker/Faculty Education(Honoraria); Boehringer Ingelheim – Investigator(Grants/Research Funding); Botaneco – Investigator(Fees); Celgene Corporation – Investigator(Fees); Coherus Biosciences – Investigator(Fees); CSL – Consultant(Fees); Cutanea Life Sciences – Investigator(Fees); Eli Lilly and Company – Advisory Board(Fees); GlaxoSmithKline – Investigator(Fees); inVentiv Health – Investigator(Fees); Janssen Pharmaceuticals, Inc – Other(Fees); Johnson & Johnson Pharmaceutical Research & Development – Investigator(Fees); Leo Pharma Inc – Advisory Board(Fees); Medimmune – Investigator(Fees); Medpace – Investigator(Fees); Merck & Co., Inc – Investigator(Fees); Merck Serono – Investigator(Fees); Novartis – Investigator(Fees); Pfizer Inc. – Advisory Board(Fees), Investigator(Fees); PhotonMD, Inc. – Investigator(Fees); PPD Inc. – Investigator(Fees); Principia Biopharma Inc – Investigator(Fees); Regeneron Pharmaceuticals, Inc. – Investigator(Fees); Reistone Biopharma – Investigator(Fees); Revian LTD. – Investigator(Fees); Samson Clinical – Founder(Patent royalties or other compensation for Intellectual Property Rights); UCB – Investigator(Fees);
Hensin Tsao, MD, PhD, FAAD
Epiphany Dermatology – Advisory Board(Honoraria), Advisory Board(Stock Options); Massachusetts General Hospital – Employee(Salary); Oncobay Clinical – Consultant (1099 relationship)(Fees); UpToDate, Inc. – Other(Honoraria); Worldcare Clinical, LLC – Consultant (1099 relationship)(Fees);
Sandy Sharon Tsao, MD, FAAD
Epiphany Dermatology – Advisory Board(Stock); Lazarus AI – Consultant(Honoraria); Oncobay – Consultant(Honoraria); Oncobay Clinical – Consultant(Honoraria); UpToDate – Other(Honoraria); WorldCare Clinical LLC – Consultant (1099 relationship)(Honoraria);
Jill S. Waibel, MD, FAAD
Allergan – Consultant (1099 relationship)(Honoraria); Amgen – Investigator(Grants/Research Funding); argenx – Investigator(Grants/Research Funding); Bristol-Myers Squibb – Investigator(Grants/Research Funding); Candela Corporation – Consultant (1099 relationship)(Honoraria); Cytrellis Biosystems, Inc – Investigator(Grants/Research Funding); Eli Lilly – Investigator(Grants/Research Funding); Galderma – Investigator(Grants/Research Funding); Horizon Pharma, Inc. – Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Procter & Gamble Company – Consultant (1099 relationship)(Honoraria); Regenx – Advisory Board(No Compensation Received), Investigator(Grants/Research Funding); Sanofi – Investigator(Grants/Research Funding); Shanghai Fudan-Zhangjiang Bio Pharmaceutical Co., Ltd. – Investigator(Grants/Research Funding); SkinCeuticals LLC – Investigator(Grants/Research Funding); VA Merit Grant – Other(No Compensation Received);
Stephan Weidinger
AbbVie – Advisory Board(Honoraria), Investigator(Fees); Almirall – Advisory Board(Honoraria), Investigator(Fees), Speaker(Honoraria); Boehringer Ingelheim – Advisory Board(Honoraria); Eli Lilly and Company – Advisory Board(Honoraria), Investigator(Fees); Galderma Germany – Advisory Board(Honoraria); Leo Pharma A/S – Advisory Board(Honoraria), Investigator(Fees), Other(Grants/Research Funding), Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Fees), Speaker(Honoraria); Sanofi Genzyme – Advisory Board(Honoraria), Investigator(Fees), Speaker(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria), Speaker(Honoraria);
Jianzhong Zhang, MD
No financial relationships exist with ineligible companies.
Qiang Zhang
No financial relationships exist with ineligible companies.
Yan Zhao, MD
No financial relationships exist with ineligible companies.